Oncology Pharma Inc.

ONPH · OTC
Analyze with AI
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Operating Activities
Net Income-$104,627-$97,473-$208-$850
Dep. & Amort.$0$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$358$326-$196$35
Other Non-Cash$104,637$97,030$380$777
Operating Cash Flow$369-$117-$22-$37
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$1,780-$322$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1,780-$322$0$0
Financing Activities
Debt Repay.$6$112$0$0
Stock Issued$1,400$334$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$18$43
Financing Cash Flow$1,406$446$18$43
Forex Effect$0$0$0$0
Net Chg. in Cash-$5$7-$5$6
Supplemental Information
Beg. Cash$9$2$7$1
End Cash$4$9$2$7
Free Cash Flow$369-$117-$22-$37